Sector: MedicalCollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 113 |
Technical : | 112 |
Performance : | 64 |
Overall: | 52 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 113 |
Technical : | 72 |
Performance : | 59 |
Overall: | 31 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 120 |
Technical : | 64 |
Performance : | 59 |
Overall: | 37 |
Number of Stocks: | 306 |
Headlines
- Earnings Summary: Wednesday, March 12, 2008
Mar 13, 2008 02:18 AM | AERG, AFCE, ALFA, AMIE, ANH, ARYX
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006 - Mar 7 2008 10:05AM
Mar 07, 2008 10:05 AM | ABM, ADSK, AMSC, ASGN, ASTE, BBI
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006 - Mar 2 2008 11:12PM
Mar 02, 2008 11:11 PM | ABM, ADSK, AMSC, ASGN, ASTE, BBI
- STREET MOVES: Two Friedman Billings Analysts Leave Firm
Feb 08, 2008 10:47 AM | AIS, BRL, CGPI, DUSA, ENDP, NSTK
- Medigene Gets EU Market Rights For CollaGenex Oracea Drug
Dec 20, 2006 03:24 AM | CGPI, MDG
- UPDATE: CollaGenex Wins FDA Approval For Oracea
May 30, 2006 04:08 PM | CGPI
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CGPI
|
Compare to S&P
|
| YTD |
73.82 %
|
86.25 %
|
| 4 Weeks |
0.61 %
|
-2.79 %
|
| 12 Weeks |
57.05 %
|
59.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 128.57 %
|
|
EPS Growth in Last Year: 107.14 %
|
|
Sales Growth in Last Quarter: 6.79 %
|
|
Sales Growth in Last Quarter: 28.65 %
|
|
